Age-related mitochondrial dysfunction as a key factor in COVID-19 disease

Area of Science:

• Gerontology
• Immunology
• Virology

Background:

• COVID-19 primarily affects the elderly, leading to severe pneumonia, cytokine storms, and multi-organ failure.
• Age-associated diseases like metabolic syndrome and diabetes are COVID-19 risk factors, increasing severity and lethality.
• Mitochondrial dysfunction is a hallmark of aging and linked to impaired immune responses and chronic inflammation.

Purpose of the Study:

• To review the association between mitochondrial dysfunction, immune response defects in aging, and COVID-19 comorbidities.
• To explore the role of mitochondrial dysfunction in the chronic inflammation driving severe COVID-19 outcomes.

Main Methods:

• Literature review focusing on aging, mitochondrial biology, immunology, and COVID-19 pathogenesis.
• Analysis of existing research linking mitochondrial dysfunction to age-related diseases and viral infections.

Main Results:

• Mitochondrial dysfunction is implicated in defective immune responses to viral infections and chronic inflammation.
• This dysfunction is prevalent in aging and age-related comorbidities that worsen COVID-19 prognosis.
• Chronic inflammation from mitochondrial dysfunction may trigger the cytokine storm in severe COVID-19.

Conclusions:

• Mitochondrial dysfunction contributes significantly to the severity of COVID-19, particularly in older individuals and those with comorbidities.
• Targeting mitochondrial health through therapies that improve turnover, dynamics, and activity could be a key preventive strategy against severe COVID-19.